IL311982A - Inhibitors of human immunodeficiency virus replication - Google Patents
Inhibitors of human immunodeficiency virus replicationInfo
- Publication number
- IL311982A IL311982A IL311982A IL31198224A IL311982A IL 311982 A IL311982 A IL 311982A IL 311982 A IL311982 A IL 311982A IL 31198224 A IL31198224 A IL 31198224A IL 311982 A IL311982 A IL 311982A
- Authority
- IL
- Israel
- Prior art keywords
- inhibitors
- immunodeficiency virus
- human immunodeficiency
- virus replication
- replication
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163255056P | 2021-10-13 | 2021-10-13 | |
| US202163257212P | 2021-10-19 | 2021-10-19 | |
| PCT/IB2022/059780 WO2023062559A1 (en) | 2021-10-13 | 2022-10-12 | Inhibitors of human immunodeficiency virus replication |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL311982A true IL311982A (en) | 2024-06-01 |
Family
ID=84044276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL311982A IL311982A (en) | 2021-10-13 | 2022-10-12 | Inhibitors of human immunodeficiency virus replication |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240423985A1 (enExample) |
| EP (1) | EP4415685A1 (enExample) |
| JP (1) | JP2024535596A (enExample) |
| KR (1) | KR20240074850A (enExample) |
| AU (1) | AU2022362855B2 (enExample) |
| CA (1) | CA3234219A1 (enExample) |
| CL (1) | CL2024001073A1 (enExample) |
| IL (1) | IL311982A (enExample) |
| MX (1) | MX2024004551A (enExample) |
| WO (1) | WO2023062559A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202128648A (zh) * | 2019-10-04 | 2021-08-01 | 英商Ｖｉｉｖ醫療保健英國(Ｎｏ 5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| WO2025169059A1 (en) | 2024-02-05 | 2025-08-14 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3347352T (lt) * | 2016-08-19 | 2019-08-12 | Gilead Sciences, Inc. | Terapiniai junginiai, naudotini živ viruso infekcijos profilaktikai arba terapiniam gydymui |
| TW202024061A (zh) * | 2017-08-17 | 2020-07-01 | 美商基利科學股份有限公司 | Hiv蛋白質膜抑制劑之固體形式 |
| CA3103522C (en) * | 2018-07-16 | 2023-11-21 | Gilead Sciences, Inc. | Capsid inhibitors for the treatment of hiv |
| MA53973A (fr) | 2018-10-24 | 2022-02-09 | Viiv Healthcare Uk No 5 Ltd | Inhibiteurs de la réplication du virus de l'immunodéficience humaine |
| EP3986561B1 (en) | 2019-06-19 | 2024-02-14 | VIIV Healthcare UK (No.5) Limited | Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication |
| EP4135702B1 (en) * | 2020-04-15 | 2026-06-03 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
-
2022
- 2022-10-12 AU AU2022362855A patent/AU2022362855B2/en active Active
- 2022-10-12 EP EP22797493.8A patent/EP4415685A1/en active Pending
- 2022-10-12 IL IL311982A patent/IL311982A/en unknown
- 2022-10-12 WO PCT/IB2022/059780 patent/WO2023062559A1/en not_active Ceased
- 2022-10-12 US US18/700,402 patent/US20240423985A1/en active Pending
- 2022-10-12 JP JP2024522260A patent/JP2024535596A/ja active Pending
- 2022-10-12 MX MX2024004551A patent/MX2024004551A/es unknown
- 2022-10-12 KR KR1020247014899A patent/KR20240074850A/ko active Pending
- 2022-10-12 CA CA3234219A patent/CA3234219A1/en active Pending
-
2024
- 2024-04-11 CL CL2024001073A patent/CL2024001073A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024535596A (ja) | 2024-09-30 |
| US20240423985A1 (en) | 2024-12-26 |
| MX2024004551A (es) | 2024-06-26 |
| CL2024001073A1 (es) | 2024-10-04 |
| KR20240074850A (ko) | 2024-05-28 |
| WO2023062559A1 (en) | 2023-04-20 |
| AU2022362855B2 (en) | 2025-08-14 |
| AU2022362855A1 (en) | 2024-05-02 |
| EP4415685A1 (en) | 2024-08-21 |
| CA3234219A1 (en) | 2023-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282240A (en) | Inhibitors of human immunodeficiency virus replication | |
| PT3917930T (pt) | Inibidores da replicação do vírus da imunodeficiência humana | |
| PT3870575T (pt) | Inibidores da replicação do vírus da imunodeficiência humana | |
| PT3619205T (pt) | Inibidores da replicação do vírus da imunodeficiência humana | |
| CY1124829T1 (el) | Παραγωγα 4'-υπoκαταστημενων νουκλεοζιδιων ως αναστολεις αντιστροφης μεταγραφασης hiv | |
| IL289925A (en) | Adenosine derivative and pharmaceutical composition comprising the same | |
| IL291285A (en) | Shp2 phosphatase inhibitors and methods of making and using the same | |
| EP3873607C0 (en) | QUINAZOLINYL-INDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF HUMAN IMMUNO DEFICIENCY VIRUS REPLICATION | |
| PL4045039T3 (pl) | Hamowanie ludzkiej integryny alfa-4beta-7 | |
| CY1124507T1 (el) | Νεος αναστολεας μεκ για τη θεραπευτικη αγωγη των ιικων και βακτηριακων λοιμωξεων | |
| EP3686201A4 (en) | INFLUENCE VIRUS REPLICATION INHIBITOR AND ITS USES | |
| DK3773593T3 (da) | Behandling af hidradenitis suppurativa under anvendelse af JAK-inhibitorer | |
| IL280932A (en) | Specially formulated compositions of inhaled nintedanib and nintedanib salts | |
| IL287768A (en) | Kcnt1 inhibitors and methods of use | |
| IL287751A (en) | Kcnt1 inhibitors and methods of use | |
| MX380276B (es) | Inhibidor jak. | |
| UY36649A (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana | |
| DK3676285T3 (da) | Vaccine til anvendelse i profylakse og/eller behandling af en sygdom | |
| IL290435A (en) | Laser-induced graphene filters and methods of making and using same | |
| PL4172157T3 (pl) | Inhibitory kapsydu w leczeniu hiv | |
| IL282227A (en) | Use of plasma and plasma fractions for improvement of pain, wound healing, and postoperative recovery | |
| IL281022A (en) | Treatment of nsclc patients refractory for anti-pd-1 antibody | |
| DK3773558T3 (da) | Kombinationsbehandling af artritisk sygdom | |
| EP4038064C0 (en) | N-SUBSTITUTED 6-OXO-1,6-DIHYDROPYRIMIDINE-2-YL DERIVATIVES AS INHIBITORS OF HUMAN IMMUNO DEFICIENCY VIRUS REPLICATION | |
| IL286485A (en) | Pi4-kinase inhibitors and methods of using the same |